At Genmab, we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.
The Role
This position will be responsible for developing and executing HTA strategy in partnership with Market Access. This role requires strong scientific leadership, knowledge of HTA processes, cross-functional influence, and external engagement experience with HTA processes/ Agencies. As part of a growing group, this role will also be in a unique position to deliver locally and contribute to global strategy while helping shape the build of the function in Europe as the company grows.
This position can be filled in the UK, France, Germany, Italy or Spain.
Responsibilities
Drives the development, execution, and implementation of the European evidence needs for HTA & post-approval RWE for Genmab products across European markets of interest in alignment with market access and medical affairs.
Co-develops the JCA submission and HTA dossier with the Market Access and Pricing Lead to ensure the evidence on clinical and economic value of Genmab products is represented in a scientifically robust manner, consistent with evolving HTA standards.
Provides input into global HEOR and RWE deliverables (e.g., economic model, global value dossier, global value evidence framework, ITC methods) re: local country needs and leads validation of regional/local input.
Leads evidence generation activities relevant to local markets including localization of global deliverables and post-approval evidence generation activities.
Develop customer-facing materials (e.g., field decks) to communicate value to access decision makers, champions the review through the MRL process and supports training of customer facing teams as appropriate.
Serves as a scientific HEOR/ RWE SME to market access in pricing and HTA negotiations.
As a member of the CORE team, contribute to department strategy and objectives as well as represent CORE on key initiatives.
As a member of the CORE team, support pipeline assets as needed.
Requirements
Graduate (PhD or Masters) degree and relevant work experience in health economics, outcomes research, epidemiology, health services research, public health, health policy
Minimum of 7 years in the pharmaceutical industry or consulting in the direct conduct of health economics, outcomes research, real world evidence and epidemiology studies
Oncology experience preferred
Strong commercial and clinical strategic mindset.
Demonstrated research accomplishments as evidenced by a history of peer-reviewed publications.
Excellent knowledge of market access environment and HTA process in key European markets.
Significant Experience participating in HTA processes at country level in Germany, France or UK.
Ability to work well in a team and cross-functional environment, as well as work independently with limited supervision.
Ability to travel. This position can be filled in the UK, France, Germany, Italy or Spain.
Ability to work successfully under pressure in a fast-paced environment and with tight timelines.
Ability to be proactive, enthusiastic and goal orientated.
Strong communication skills - both oral and written.
About You
Locations
Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.
About Genmab
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
Our commitment to diversity, equity, and inclusion
We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).
Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.
betstamp
BruntWork
Into City Prep
Into City Prep
Snappet
